Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
about
Second and third line treatment options for Helicobacter pylori eradicationOptimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Treatment of Helicobacter pylori infection: Past, present and futureEfficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.Helicobacter pylori: management in 2013.Fluoroquinolone-based protocols for eradication of Helicobacter pyloriTreatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Treatment of Helicobacter pylori infection 2014.Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection.Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.Comparison of 10 days levofloxacin bismuth based quadruple therapy and levofloxacin based triple therapy for Helicobacter pylori therapy.Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy.Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.Second-line rescue treatment of infection: Where are we now?
P2860
Q26829666-ED4A10E1-F11F-41E5-935C-C5C8BC99D5DAQ33626779-09CA423B-920E-47C3-985D-D22CFCECF70CQ34508830-9373BD88-9A64-43A9-A967-A164C075E18CQ35666640-113AABA7-8409-48A5-BD69-65A28D456F62Q38191566-4DAC56F6-FC9F-4B77-B38F-5FF9DE1F7200Q38212214-1F83B67F-5BA4-472B-A36F-7D65A45401BAQ38235943-1AEA392D-C891-42EA-A5CE-BDC2028FB5BCQ38238745-8CBFA949-6FFA-4FF8-9D55-097BE5B4BDB9Q38244257-2FD8AD4A-597A-4695-A2B8-F17FC5108BFDQ38496942-31719114-C0C0-4B6F-BF7E-C8BCC9C513E8Q38669912-426EC120-8BD9-421C-915F-C364B1B874AAQ38865607-E95AB785-DEFB-4BEA-A698-57193E315862Q39135143-EF66DF86-43BB-4392-9354-5EAC0410A734Q40160459-366E9756-AA85-4EF2-81B9-E7BDC3F03E4FQ40582588-DD0FFB84-ADC1-4648-96FE-AAC1A1C8A6E3Q41471323-3817195E-AF92-4FC9-9C26-D01CB29D7C72Q41694687-F9660AE1-5314-4E9C-8291-77E73C8D10BDQ44247194-D509C28D-82C5-48F6-95BA-A64CFB27FAB9Q58602176-06782F29-4FD5-45FF-B5EB-9F744011D43B
P2860
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Second-line rescue triple ther ...... eradicate H. pylori infection.
@en
Second-line rescue triple ther ...... eradicate H. pylori infection.
@nl
type
label
Second-line rescue triple ther ...... eradicate H. pylori infection.
@en
Second-line rescue triple ther ...... eradicate H. pylori infection.
@nl
prefLabel
Second-line rescue triple ther ...... eradicate H. pylori infection.
@en
Second-line rescue triple ther ...... eradicate H. pylori infection.
@nl
P2093
P2860
P50
P1476
Second-line rescue triple ther ...... eradicate H. pylori infection
@en
P2093
Gemma Vinagre
Javier Molina-Infante
Jesus Barrio
P2860
P304
P356
10.3109/00365521.2013.786132
P577
2013-04-05T00:00:00Z